Unlocking the potential of agonist antibodies for treating cancer using antibody engineering is a research paper published in Trends in Molecular Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 25 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Science Foundation
Grant: 1605266
National Science Foundation
Grant: 1804313
Collaborative Research: GOALI: Nanoparticle analysis of antibody colloidal interactions and their influence on viscoelastic properties of concentrated antibody solutions
National Science Foundation
Grant: CBET 1813963
National Institutes of Health
Grant: R35GM136300
National Institutes of Health
Grant: RF1AG059723
US Office of Congressionally Directed Medical Research Programs
Grant: W81XWH-21-1-0040
National Institutes of Health
Grant: 5R35GM136300-04
Structure-guided antibody targeting of pre-selected epitopes in amyloidogenic aggregates
National Science Foundation
Grant: 1813963
GOALI: Methods for designing antibodies specific for intrinsically disordered proteins
National Institutes of Health
Grant: 3RF1AG059723-01S1
Design and Evolution of Polyvalent Domain Antibodies Specific for Tau Aggregates
U.S. Department of Defense
FWCI
3.13
Citation Percentile
0.9%
Influential Citations
2
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals